Cargando…
Nuclear osteopontin-c is a prognostic breast cancer marker
BACKGROUND: Although Osteopontin has been known as a marker for cancer progression, the elevated production of this cytokine is not specific for cancer. We have identified the splice variant Osteopontin-c as being absent from healthy tissue but associated with about 75% of breast cancer cases. Howev...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333500/ https://www.ncbi.nlm.nih.gov/pubmed/25625274 http://dx.doi.org/10.1038/bjc.2014.664 |